---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-061354"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2024-07-15T23:59:59+00:00"
generated_at: "2026-05-31T20:43:45.202967+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Unicycive Therapeutics receives Nasdaq bid price deficiency notice; 180 days to regain compliance

## Summary
- Received Nasdaq notice on July 9, 2024 for bid price below $1.00 for 30 consecutive business days.
- Has until January 6, 2025 to regain compliance by closing at $1.00+ for ten consecutive business days.
- Stock continues trading on Nasdaq Capital Market under symbol UNCY; company may consider options.
- If not compliant by Jan 6, 2025, may qualify for second 180-day period or face delisting with appeal rights.

## SEC filing metadata
- accession: 0001213900-24-061354
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2024-07-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390024061354/0001213900-24-061354-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390024061354/ea0209297-8k_unicycive.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-061354
- JSON: https://secwatch.observer/filing/0001213900-24-061354.json
- Plain text: https://secwatch.observer/filing/0001213900-24-061354.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.